Premier Fund Managers’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-87,561
Closed -$255K 227
2023
Q1
$255K Sell
87,561
-96,184
-52% -$485K 0.01% 219
2022
Q4
$1.2M Sell
183,745
-120,000
-40% -$566K 0.05% 162
2022
Q3
$887K Hold
303,745
0.07% 118
2022
Q2
$1.05M Sell
303,745
-107,009
-26% -$311K 0.05% 169
2022
Q1
$1.26M Hold
410,754
0.04% 182
2021
Q4
$1.73M Hold
410,754
0.06% 162
2021
Q3
$2.65M Hold
410,754
0.09% 170
2021
Q2
$6.55M Hold
410,754
0.22% 112
2021
Q1
$5M Buy
410,754
+329,854
+408% +$5.06M 0.19% 128
2020
Q4
$887K Hold
80,900
0.04% 203
2020
Q3
$408K Buy
80,900
+7,500
+10% +$28.5K 0.02% 201
2020
Q2
$143K Buy
+73,400
New +$151K 0.01% 206

Other funds holding STIM

Premier Fund Managers's STIM Position: Q2 2023 in Review

Premier Fund Managers sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 87,561 shares — an estimated $255K sold.

Premier Fund Managers first reported a position in STIM in Q2 2020 and held it in 12 quarters. The position peaked at $6.55M in Q2 2021. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

  • Premier Fund Managers reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
  • Premier Fund Managers sold 87,561 Neuronetics shares in Q2 2023, an estimated $255K.
  • Premier Fund Managers first reported a position in Neuronetics in Q2 2020 and held it in 12 quarters.
  • Premier Fund Managers's Neuronetics position peaked at $6.55M in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Premier Fund Managers's 13F filing for Q2 2023, filed 3 Aug 2023.